{"title":"Correction to “Cinchonine and Cinchonidine Alleviate Cisplatin-Induced Ototoxicity by Regulating PI3K-AKT Signaling”","authors":"","doi":"10.1111/cns.70228","DOIUrl":null,"url":null,"abstract":"<p>D. Tang, X. Wang, J. Wu, Y. Li, C. Li, X. Qiao, L. Fan, Y. Chen, H. Zhu, Z. Zhang, and Y. He, “Cinchonine and Cinchonidine Alleviate Cisplatin-Induced Ototoxicity by Regulating PI3K-AKT Signaling,” <i>CNS Neuroscience & Therapeutics</i> 30, no. 2 (2024): e14403, https://doi.org/10.1111/cns.14403.</p><p>We apologize for this error.</p>","PeriodicalId":154,"journal":{"name":"CNS Neuroscience & Therapeutics","volume":"31 1","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744361/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS Neuroscience & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cns.70228","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
D. Tang, X. Wang, J. Wu, Y. Li, C. Li, X. Qiao, L. Fan, Y. Chen, H. Zhu, Z. Zhang, and Y. He, “Cinchonine and Cinchonidine Alleviate Cisplatin-Induced Ototoxicity by Regulating PI3K-AKT Signaling,” CNS Neuroscience & Therapeutics 30, no. 2 (2024): e14403, https://doi.org/10.1111/cns.14403.
期刊介绍:
CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.